Geode Capital Management, LLC Protara Therapeutics, Inc. Transaction History
Geode Capital Management, LLC
- $1.26 Trillion
- Q4 2024
A detailed history of Geode Capital Management, LLC transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 179,593 shares of TARA stock, worth $763,270. This represents 0.0% of its overall portfolio holdings.
Number of Shares
179,593
Previous 170,040
5.62%
Holding current value
$763,270
Previous $311,000
202.89%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding TARA
# of Institutions
45Shares Held
11.8MCall Options Held
9KPut Options Held
1.8K-
Ra Capital Management, L.P. Boston, MA1.9MShares$8.08 Million0.05% of portfolio
-
Opaleye Management Inc. Boston, MA1.68MShares$7.14 Million0.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.36MShares$5.78 Million0.0% of portfolio
-
Stem Point Capital LP New York, NY943KShares$4.01 Million0.52% of portfolio
-
Woodline Partners LP San Francisco, CA852KShares$3.62 Million0.01% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $47.9M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...